Bain Capital Public Equity Management Ii, LLC Horizon Therapeutics Public LTD CO Transaction History

Bain Capital Public Equity Management Ii, LLC

$2.08 Billion
Q2 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $74.9 Million - $110 Million	-943,219 Reduced 73.32%	343,152 $27.4 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $55.2 Million - $70.2 Million	638,875 Added 98.67%	1,286,371 $135 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $24 Million - $29.2 Million	-243,874 Reduced 27.36%	647,496 $69.8 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $371,867 - $446,557	4,046 Added 0.46%	891,370 $97.6 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $6.79 Million - $7.55 Million	-78,727 Reduced 8.15%	887,324 $83.1 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $7.13 Million - $9.48 Million	-99,250 Reduced 9.32%	966,051 $88.9 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $52.5 Million - $66.1 Million	783,253 Added 277.7%	1,065,301 $77.9 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $15.6 Million - $22.5 Million	282,048 New	282,048 $21.9 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $831,164 - $1.57 Million	-27,522 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $684,472 - $1.06 Million	27,522 New	27,522 $815,000
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $15.9 Million - $22.9 Million	-625,270 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $14.4 Million - $17.5 Million	625,270 New	625,270 $17 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Account